Structure of a cyclin-dependent kinase from Giardia lamblia
Author Information
Author(s): Leibly David J., Newling Paul A., Abendroth Jan, Guo Wenjin, Kelley Angela, Stewart Lance J., Van Voorhis Wesley
Primary Institution: Seattle Structural Genomics Center for Infectious Disease
Hypothesis
The cyclin-dependent kinase from Giardia lamblia may serve as a potential drug target for giardiasis treatment.
Conclusion
The study presents the first structure of a cyclin-dependent kinase from Giardia lamblia, which shows potential for selective inhibition as a drug target.
Supporting Evidence
- The study presents the first structure of a cyclin-dependent kinase from Giardia lamblia.
- The structure was determined at a resolution of 1.85 Å for the apo form and 2.0 Å for the AMP-bound form.
- GlCDK shows significant sequence homology to human CDKs, indicating potential for selective inhibition.
- Crystallization was achieved without optimization, indicating the protein's stability.
- AMP was shown to bind to the apo protein, suggesting its role in the kinase activity.
Takeaway
Scientists studied a protein from a tiny parasite that makes people sick. They found out what it looks like, which could help make new medicines.
Methodology
The gene encoding the CDK was PCR-amplified, cloned, expressed in E. coli, and purified for crystallization and structure determination.
Limitations
The structure of the CDK-cyclin complex was not solved, and the functional role of the cyclin partner remains unclear.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website